there are lingering effects from covid giving this treatment from chnc possibilities. we know and I know from chatting with the CEO they're in negotiations with potential partners and Gilead looks for opportunities just like this. is anything known for sure? knowing is insider intel you know that.
since the SS is unchanging and they have no debt I'm excited to find out...
News 
Market Data 
Discover 
